Glenmark Life Sciences

1,151.85
-37.00
(-3.11%)
Market Cap (₹ Cr.)
₹14,571
52 Week High
1,335.10
Book Value
₹
52 Week Low
611.20
PE Ratio
32.61
PB Ratio
6.25
PE for Sector
38.21
PB for Sector
4.52
ROE
21.84 %
ROCE
67.73 %
Dividend Yield
1.89 %
EPS
₹36.48
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
4.80 %
Net Income Growth
0.84 %
Cash Flow Change
35.13 %
ROE
-7.55 %
ROCE
-8.31 %
EBITDA Margin (Avg.)
-2.44 %

Financial Results

Balance Sheet

Cash Flow

Share Holding

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,865.75 4,43,025.22 42.01 49,887.17 12.06 9,648 42.62 67.36
1,638.65 1,32,315.81 29.77 26,520.66 14.17 4,155 17.77 55.74
6,551.15 1,08,578.89 19.51 28,905.40 12.36 5,578 -0.90 37.61
1,054.60 1,06,092.28 25.45 19,831.50 13.82 3,831 30.78 29.73
2,151.70 98,990.94 43.74 20,141.50 19.94 1,936 77.69 47.69
2,535.75 97,396.59 49.63 10,615.63 19.57 1,942 9.89 64.69
1,496.35 89,493.33 24.95 29,559.25 17.55 3,169 61.17 44.33
6,086.75 73,392.58 34.14 12,978.42 9.84 1,811 91.18 52.95
1,636.75 46,593.50 - 12,653.09 6.58 -1,831 96.52 46.54
365.35 43,311.65 27.75 15,621.20 35.25 1,298 478.78 49.52

Corporate Action

Technical Indicators

RSI(14)
Neutral
51.92
ATR(14)
Less Volatile
58.64
STOCH(9,6)
Neutral
62.60
STOCH RSI(14)
Oversold
14.21
MACD(12,26)
Bearish
-7.91
ADX(14)
Very Strong Trend
54.21
UO(9)
Bearish
49.52
ROC(12)
Uptrend But Slowing Down
7.13
WillR(14)
Neutral
-61.16